Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

This study has been completed.

Sponsor:

Information provided by:

MEDA Pharma GmbH & Co. KG

ClinicalTrials.gov Identifier:

NCT00328601

First received: May 19, 2006

Last updated: July 29, 2008

Last verified: July 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	June 2005
Estimated Primary Completion Date:	No date given

No publications provided by MEDA Pharma GmbH & Co. KG

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006 Nov;29(11):2365-70.

To Top